Tactile Systems Technology Inc (TCMD) is not a strong buy at the moment for a beginner, long-term investor. While the company has shown strong financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and insider selling raises concerns. Additionally, there are no significant trading signals or recent news catalysts to support an immediate buy decision.
The MACD is negative and contracting (-0.227), indicating bearish momentum. RSI is at 15.522, signaling the stock is oversold. The stock is trading near its S1 support level (23.763) but below the pivot (25.264), suggesting limited upward momentum in the short term.

Strong Q4 financial performance with YoY revenue growth of 21.04%, net income growth of 9.45%, and EPS growth of 15%. Analysts have raised price targets significantly, with multiple firms maintaining Buy or Overweight ratings. The company's lymphedema business is expected to grow 8%-11%, driven by strong execution.
Insider selling has increased by 867.75% in the last month, which could indicate a lack of confidence from insiders. Hedge funds are neutral, and there are no significant trading trends. Technical indicators show bearish momentum, and the stock is oversold. No recent news or event-driven catalysts.
In Q4 2025, revenue increased by 21.04% YoY to $103.59M. Net income grew by 9.45% YoY to $10.63M, and EPS rose by 15% to $0.46. Gross margin improved to 77.62%, up 4.23% YoY, indicating strong operational efficiency.
Analysts are generally positive, with several firms raising price targets (e.g., Piper Sandler to $42, Lake Street to $40, BTIG to $38). However, B. Riley maintains a Neutral rating, citing limited upside from current levels despite strong Q4 results.